Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lorus Therapeutics cleared to initiate clinical trials of GTI-2040

Dec. 13, 1999

Vion's TAPET administered to first patients intratumorally in phase I trial

Dec. 13, 1999

A6/cyclophosphamide combination to be studied as antimetastatic therapy

Dec. 13, 1999

Water-soluble mesilate salt form of known antitumor agent prepared at Pfizer

Dec. 13, 1999

Ribozyme to form joint venture with Elan for breast cancer therapeutic

Dec. 13, 1999

Boehringer Ingelheim assumes full responsibility for continued development of novel antitumor agent

Dec. 13, 1999

IB-367 rinse effectively reduces mucositis in BMT recipients

Dec. 10, 1999

Another phase II clinical trial begins with ImClone's C225 for new cancer indication

Dec. 10, 1999

Theratechnologies' PDT strategy validated in study reported at ASH

Dec. 10, 1999

Reversible inhibitors of methionine aminopeptidase-2 as antiangiogenic agents

Dec. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...